---
title: "Eli Lilly's drug combined with Wegovy can reduce muscle loss"
description: "Research shows that Eli Lilly's drug bimagrumab, when used in combination with Novo Nordisk's weight loss drug Wegovy, can effectively reduce muscle loss. According to results announced at the America"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/245725786.md"
published_at: "2025-06-23T13:42:53.000Z"
---

# Eli Lilly's drug combined with Wegovy can reduce muscle loss

> Research shows that Eli Lilly's drug bimagrumab, when used in combination with Novo Nordisk's weight loss drug Wegovy, can effectively reduce muscle loss. According to results announced at the American Diabetes Association annual meeting, patients lost 22.1% of their body weight over 48 weeks, with 92.8% of that being fat loss. This study provides a potential solution to the muscle loss issue associated with obesity medications. Eli Lilly's stock price rose by more than 3%

Research shows that patients using Novo Nordisk's weight loss drug Wegovy in combination with Eli Lilly's experimental drug bimagrumab can effectively maintain muscle mass while losing weight. According to results announced at the American Diabetes Association annual meeting held in Chicago on Monday, patients on the combination therapy lost 22.1% of their body weight over 48 weeks, with 92.8% of that being fat loss. These findings provide a potential solution to the muscle loss issue associated with currently popular obesity medications. Researchers are also exploring other drug combinations, but these combinations may carry a higher risk of side effects. Eli Lilly is currently up over 3%

### Related Stocks

- [LLY.US - Eli Lilly](https://longbridge.com/en/quote/LLY.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Lilly's Moment: AI-Powered Pipeline Positions Shares to Surge in 2026 | Eli Lilly's stock is surging due to AI deals and a favorable drug pricing agreement. The healthcare sector, particularly | [Link](https://longbridge.com/en/news/267579204.md) |
| Eli Lilly joins a very exclusive club | Eli Lilly becomes the eleventh company to surpass $1 trillion in market capitalization, marking a milestone for healthca | [Link](https://longbridge.com/en/news/267672421.md) |
| Did Analyst Upgrades and Metal Price Tailwinds Just Shift Coeur Mining's (CDE) Investment Narrative? | Recent analyst upgrades for Coeur Mining, alongside rising gold and silver prices, have shifted focus on the company's c | [Link](https://longbridge.com/en/news/275995095.md) |
| Manappuram Finance Says RBI Grants Approval For Bain Capital To Acquire Joint Control In Co | Manappuram Finance Ltd :MANAPPURAM FINANCE LTD - RBI GRANTS APPROVAL FOR BAIN CAPITAL TO ACQUIRE JOINT CONTROL IN MANAPP | [Link](https://longbridge.com/en/news/275983986.md) |
| Aberdeen Group plc Has $144.09 Million Position in Arista Networks, Inc. $ANET | Aberdeen Group plc increased its stake in Arista Networks, Inc. by 1.4% in Q3, owning 1,005,027 shares valued at $144.09 | [Link](https://longbridge.com/en/news/275999141.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.